Tilray Brands (TLRY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Sep, 2026Executive summary
Annual meeting scheduled for November 18, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by November 17, 2026.
Voting matters and shareholder proposals
Election of three directors for terms expiring in 2029: David Clanachan, Renah Persofsky, and Irwin Simon.
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal year ending May 31, 2027.
Approval of governance changes to declassify the board and allow annual election of all directors, and to remove the 'for cause' requirement for director removal.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Proposal to amend the charter to declassify the board, shifting to annual elections for all directors.
Proposal to eliminate the charter provision restricting director removal to 'for cause' only.
Latest events from Tilray Brands
- Virtual meeting to elect directors, ratify auditor, and approve Board declassification.TLRY
Proxy filing - Virtual meeting to vote on board declassification, director elections, and auditor ratification.TLRY
Proxy filing - Record revenue and adjusted EBITDA highlight strong growth and international expansion.TLRY
Q4 2026 - Record Q3 revenue, improved profitability, and strong international cannabis growth.TLRY
Q3 2026 - Acquisition creates a $500M global craft beverage platform, driving EBITDA and international growth.TLRY
M&A announcement - Record Q2 revenue, improved cash flow, and strong cannabis and distribution growth boost outlook.TLRY
Q2 2026 - Record revenue growth, margin gains, and cost synergies support a strong FY2025 outlook.TLRY
Q4 2024 - Q3 net revenue was $185.8M, with improved margins but a $793.5M net loss from impairments.TLRY
Q3 2025 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies driving growth.TLRY
Q2 2025